CN1112186C - 含有葡萄糖酯衍生物的脑代谢改善剂 - Google Patents
含有葡萄糖酯衍生物的脑代谢改善剂 Download PDFInfo
- Publication number
- CN1112186C CN1112186C CN94190820A CN94190820A CN1112186C CN 1112186 C CN1112186 C CN 1112186C CN 94190820 A CN94190820 A CN 94190820A CN 94190820 A CN94190820 A CN 94190820A CN 1112186 C CN1112186 C CN 1112186C
- Authority
- CN
- China
- Prior art keywords
- glucose
- acetyl group
- cerebral tissue
- cerebral
- metabolism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP298870/1993 | 1993-10-22 | ||
JP29887093A JP3645580B2 (ja) | 1993-10-22 | 1993-10-22 | グルコースエステル誘導体を含有する脳代謝改善剤 |
JP298870/93 | 1993-10-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1115963A CN1115963A (zh) | 1996-01-31 |
CN1112186C true CN1112186C (zh) | 2003-06-25 |
Family
ID=17865258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94190820A Expired - Fee Related CN1112186C (zh) | 1993-10-22 | 1994-10-17 | 含有葡萄糖酯衍生物的脑代谢改善剂 |
Country Status (8)
Country | Link |
---|---|
US (1) | US5739117A (zh) |
EP (1) | EP0676205B1 (zh) |
JP (1) | JP3645580B2 (zh) |
KR (1) | KR950703977A (zh) |
CN (1) | CN1112186C (zh) |
CA (1) | CA2152357A1 (zh) |
DE (1) | DE69433810D1 (zh) |
WO (1) | WO1995011031A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE229968T1 (de) * | 1996-03-28 | 2003-01-15 | Nihon Mediphysics Co Ltd | Diagnostisches mittel zur glykostoffwechselfunktion |
US20050245612A1 (en) * | 2004-05-03 | 2005-11-03 | Blass John P | Pharmaceutical compositions for metabolic insufficiencies |
EP1032403B1 (en) | 1997-10-24 | 2012-05-02 | John P. Blass | Nutritional supplement for cerebral metabolic insufficiencies |
EP2319508A1 (en) | 2000-05-01 | 2011-05-11 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
EP1605950A4 (en) * | 2003-03-06 | 2008-01-09 | Accera Inc | NOVEL CHEMICAL ENTITIES AND METHODS OF USE IN THE TREATMENT OF METABOLIC DISORDERS |
JP4942141B2 (ja) * | 2004-12-02 | 2012-05-30 | 江崎グリコ株式会社 | カルボキシル基への糖転移方法 |
LT2500017T (lt) | 2006-04-03 | 2017-12-11 | Accera, Inc. | Ketogeninių junginių panaudojimas senatvinio atminties susilpnėjimo gydymui |
ES2556535T3 (es) | 2007-07-31 | 2016-01-18 | Accera, Inc. | Uso de ensayo genómico y compuestos cetogénicos para tratamiento de una función cognitiva reducida |
US8105809B2 (en) | 2008-07-03 | 2012-01-31 | Accera, Inc. | Enzymatic synthesis of acetoacetate esters and derivatives |
AU2009266869B2 (en) | 2008-07-03 | 2016-07-07 | Cerecin Inc. | Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
WO2023168329A2 (en) * | 2022-03-02 | 2023-09-07 | Mitopower, Inc. | Novel prodrugs derived from nicotinic acid and ribose |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6094992A (ja) * | 1983-10-28 | 1985-05-28 | Sankyo Co Ltd | グリゼオ−ル酸誘導体 |
JPS60502056A (ja) * | 1983-08-01 | 1985-11-28 | ザ マクリ−ン ホスピタル コ−ポレ−シヨン | Gabaエステル類およびgaba類似体エステル類 |
JPS6299324A (ja) * | 1985-10-25 | 1987-05-08 | Wakunaga Pharmaceut Co Ltd | 脳循環代謝改善剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444743A (en) * | 1981-09-15 | 1984-04-24 | Nihon Medi-Physics Co., Ltd. | Radioactive diagnostic agent and its preparation |
RO87311B (ro) * | 1983-10-04 | 1985-12-01 | Nicolaie Oita | Medicament cu actiune metabolica complexa si procedeu de obtinere a acestuia |
DE3723826A1 (de) * | 1987-07-18 | 1989-01-26 | Henkel Kgaa | Verfahren zur herstellung von alkylglykosiden |
JP2690018B2 (ja) * | 1989-07-13 | 1997-12-10 | 日本メジフィジックス株式会社 | グルコサミン誘導体よりなる放射性診断剤 |
-
1993
- 1993-10-22 JP JP29887093A patent/JP3645580B2/ja not_active Expired - Fee Related
-
1994
- 1994-10-17 DE DE69433810T patent/DE69433810D1/de not_active Expired - Lifetime
- 1994-10-17 US US08/446,587 patent/US5739117A/en not_active Expired - Fee Related
- 1994-10-17 CN CN94190820A patent/CN1112186C/zh not_active Expired - Fee Related
- 1994-10-17 WO PCT/JP1994/001741 patent/WO1995011031A1/ja active IP Right Grant
- 1994-10-17 CA CA002152357A patent/CA2152357A1/en not_active Abandoned
- 1994-10-17 KR KR1019950702566A patent/KR950703977A/ko not_active Application Discontinuation
- 1994-10-17 EP EP94929671A patent/EP0676205B1/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60502056A (ja) * | 1983-08-01 | 1985-11-28 | ザ マクリ−ン ホスピタル コ−ポレ−シヨン | Gabaエステル類およびgaba類似体エステル類 |
JPS6094992A (ja) * | 1983-10-28 | 1985-05-28 | Sankyo Co Ltd | グリゼオ−ル酸誘導体 |
JPS6299324A (ja) * | 1985-10-25 | 1987-05-08 | Wakunaga Pharmaceut Co Ltd | 脳循環代謝改善剤 |
Also Published As
Publication number | Publication date |
---|---|
KR950703977A (ko) | 1995-11-17 |
JPH07118155A (ja) | 1995-05-09 |
JP3645580B2 (ja) | 2005-05-11 |
EP0676205A4 (en) | 1999-06-02 |
DE69433810D1 (de) | 2004-07-01 |
EP0676205A1 (en) | 1995-10-11 |
US5739117A (en) | 1998-04-14 |
CN1115963A (zh) | 1996-01-31 |
CA2152357A1 (en) | 1995-04-27 |
WO1995011031A1 (fr) | 1995-04-27 |
EP0676205B1 (en) | 2004-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1112186C (zh) | 含有葡萄糖酯衍生物的脑代谢改善剂 | |
Bruttomesso et al. | Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. | |
Gladden | Lactate metabolism: a new paradigm for the third millennium | |
Constantin et al. | Bradycardia and syncope as manifestations of partial epilepsy | |
Constable et al. | Glycogen resynthesis in leg muscles of rats during exercise | |
Bellush et al. | Stress and behavior in streptozotocin diabetic rats: Biochemical correlates of passive avoidance learning. | |
JPH04243830A (ja) | 糖尿病の末梢合併症を薬理的に治療する際に使用するためのウリジン | |
Efendić et al. | Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in healthy, prediabetic, and diabetic subjects | |
Asnis et al. | Endocrine responses to thyrotropin-releasing hormone in major depressive disorders | |
Brodows et al. | Mechanism of plasma cyclic AMP response to hypoglycemia in man | |
Jarmukli et al. | Effect of raised plasma β endorphin concentrations on peripheral pain and angina thresholds in patients with stable angina | |
LERNER | The augmentation effect of secretin on the insulin responses to known stimuli: specificity for glucose | |
Gilman et al. | Pharmacokinetic considerations in the treatment of childhood epilepsy | |
DE3875107T2 (de) | Verwendung von fructose-1,6-diphosphat zur behandlung von akuten alkoholvergiftungen und chronischem alkoholismus und verwandte pharmazeutische zusammensetzungen. | |
Russek et al. | Anorexia elicited by different catecholamines in rats | |
Waalkes et al. | The effect of reserpine on histamine and serotonin | |
Chait et al. | Acceleration of low-density lipoprotein catabolism in man by total parenteral nutrition | |
Hyde et al. | Diurnal variation in tardive dyskinesia | |
Natelson et al. | Clinical biochemistry of epilepsy. I. Nature of the disease and a review of the chemical findings in epilepsy. | |
THOMPSON et al. | Studies on a Long-acting Vitamin B12Preparation | |
LERNER | Augmented insulin responses to glucose after secretin priming in diabetic subjects | |
YOUNG et al. | The Effect of Insulin on the Metabolism of Parenteral Maltose in Man Maltose in Man | |
BIRD et al. | Abnormal function of endocrine pancreas and anterior pituitary in Friedreich's ataxia: studies in a family | |
O'Dell et al. | Zinc deficiency and peripheral neuropathy in chicks | |
EP1320372B1 (en) | Use of sulfatides for treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CI01 | Correction of invention patent gazette |
Correction item: Applicant Correct: Fujimoto Pharmaceutical Corporation False: Fujimoto Pharmaceutical Corporation|Heng Shanyang|Fumio Yoneda Number: 5 Page: 127 Volume: 12 |
|
ERR | Gazette correction |
Free format text: CORRECT: APPLICANT; FROM: FUJIMOTO PHARMACEUTICAL CO., LTD. YOKOYAMA YANGMI TIANWENLANG TO: FUJIMOTO PHARMACEUTICAL CO., LTD. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: FUJIMOTO PHARMACEUTICAL CO., LTD. TO: FUJIMOTO BROTHERS CO LTD |
|
CP01 | Change in the name or title of a patent holder |
Address after: Japan's Osaka West of the city of Songyuan in the big 1 chome 3 No. 40 Applicant after: Tomoyishi Motopulazez Corp. Address before: Japan's Osaka West of the city of Songyuan in the big 1 chome 3 No. 40 Applicant before: Fujimoto Pharmaceutical Corporation |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |